Bharat Parenterals has planned to acquire additional 18,00,000 equity shares of Rs 10 each of Varenyam Biolifesciences, being held by Varenyam Healthcare and as a consideration will issue its 11992 Equity shares on a preferential basis subject to necessary approval.
Pursuant to the proposed acquisition, Varenyam Biolifesciences becomes wholly owned subsidiary (WOS) Company, so that the company will have better control over and run the business in a manner required. The business of the Company is not outside the main line of business of the listed entity. The said acquisition is expected to be completed by June 30, 2024 subject to approval of shareholders.
Bharat Parenterals is engaged in to the business of the Pharmaceuticals & Drugs.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: